Literature DB >> 10332481

CD1a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated.

A J Troy1, P J Davidson, C H Atkinson, D N Hart.   

Abstract

PURPOSE: In this study, we employed similar techniques to detail dendritic cell subsets within bladder transitional cell carcinoma and kidney transitional cell carcinoma.
MATERIALS AND METHODS: To identify both the CD1a+ and CD1a- antigen-expressing dendritic cell populations we employed a double labeling technique to identify non-lineage-expressing leukocytes similar to that employed to isolate blood dendritic cells.
RESULTS: Dendritic cells were found in significant numbers within both bladder and kidney derived transitional cell carcinoma. Almost all the dendritic cells among the tumor cells belonged to the CD1a+ subset of epithelial dendritic cells. Similar numbers of dendritic cells were observed in the lamina propria adjacent to the tumor. These dendritic cells belonged predominantly to the CD1a- subset. These differences appear to reflect the different dendritic cell phenotypes reported for the epidermis and dermis.
CONCLUSIONS: The number of dendritic cells increased as the grade of the tumor increased, reflecting an overall higher leukocyte density in higher grade tumors. However, a possible trend for less dendritic cell activation in higher grade cancers was noted, raising the intriguing possibility that this might be a relevant prognostic factor, to be confirmed in a larger study.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10332481

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells.

Authors:  Mylène A Carrascal; Paulo F Severino; M Guadalupe Cabral; Mariana Silva; José Alexandre Ferreira; Fernando Calais; Hermínia Quinto; Cláudia Pen; Dário Ligeiro; Lúcio Lara Santos; Fabio Dall'Olio; Paula A Videira
Journal:  Mol Oncol       Date:  2014-03-06       Impact factor: 6.603

2.  Immunosuppressive effect of renal cell carcinoma on phenotype and function of dendritic cells.

Authors:  Lichen Teng; Yongsheng Chen; Dexin Ding; Hongshuang Dai; Guobin Liu; Changfu Li
Journal:  Int Urol Nephrol       Date:  2013-11-08       Impact factor: 2.370

3.  HLA-DR+ immature cells exhibit reduced antigen-presenting cell function but respond to CD40 stimulation.

Authors:  Alberto Pinzon-Charry; Tammy Maxwell; Sandro Prato; Colin Furnival; Chris Schmidt; José Alejandro López
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

4.  A population of HLA-DR+ immature cells accumulates in the blood dendritic cell compartment of patients with different types of cancer.

Authors:  Alberto Pinzon-Charry; Christopher S K Ho; Richard Laherty; Tammy Maxwell; David Walker; Robert A Gardiner; Linda O'Connor; Christopher Pyke; Chris Schmidt; Colin Furnival; José Alejandro López
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

5.  Chemokine-mediated distribution of dendritic cell subsets in renal cell carcinoma.

Authors:  Peter Middel; Sven Brauneck; Werner Meyer; Heinz-Joachim Radzun
Journal:  BMC Cancer       Date:  2010-10-22       Impact factor: 4.430

6.  Angiogenesis and dendritic cell density are not correlated with metachronous distant metastasis in curatively operated rectal cancer.

Authors:  K Günther; T Radkow; M A Reymond; R Pflüger; A Dimmler; W Hohenberger; T Papadopoulos
Journal:  Int J Colorectal Dis       Date:  2003-02-08       Impact factor: 2.571

Review 7.  Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.

Authors:  Mark P Simons; William M Nauseef; Thomas S Griffith
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

8.  Clinical evaluation of systemic and local immune responses in cancer: time for integration.

Authors:  Dmitriy W Gutkin; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2013-10-08       Impact factor: 6.968

Review 9.  Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies-A review.

Authors:  Sandeep Nayar; Prokar Dasgupta; Christine Galustian
Journal:  Oncoimmunology       Date:  2015-03-19       Impact factor: 8.110

10.  CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer.

Authors:  B J Coventry; J Morton
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.